By:
On:


Close to a dozen chiefs of India Inc who met the United States President Donald Trump lauded him for relaxing regulations that improved the business environment. The President at the same time talked about his achievements during his Presidential term and pitched for his re-election.


Mukesh Ambani, chairman and managing director of Reliance Industries, said they were looking to invest close to $7 billion in the US. “We are the only Indian company that does not use Chinese components,” Ambani said, to which Trump quipped, “Huawei you mean?”



In May 2019, Trump ordered the blacklisting of Huawei, accusing it of aiding the Chinese government in espionage. The US government also banned the company from accessing US supply chains, which it needs to make its products.


Ambani also said Trump’s leadership inspired tax relief in India. “India followed the US

…

By:
On:


India and the US can do a larger trade deal much faster, Commerce and Industry Minister Piyush Goyal said on Tuesday.


“I am delighted that both the leaders (Prime Minister Narendra Modi and US President Donald Trump) have decided to formally engage to move towards a free trade agreement (FTA) between the two big economies and my own sense is that America also will gain very significantly with this partnership,” said Goyal.



The minister said he didn’t see this engagement to be like earlier free trade negotiations that go on for decades. Modi and Trump on Tuesday held delegation-level talks on key issues such as trade and energy cooperation.


The minister was speaking at an event organised by the Confederation of Indian Industry (CII) and the US-India Business Council (USIBC) on “The India-US business story: Opportunity, innovation, entrepreneurship”. The

…

By:
On:


With Wuhan-based coronavirus spreading fast outside mainland China, risks to global economies could become more pronounced in the next quarter at a time when the global growth is slowing. While the potentially slower global growth is being reflected in our debt market with yields trending lower, it has not yet been reflected in our equity market, SHYAMSUNDAR BHAT, chief investment officer of Exide Life Insurance, tells Nikita Vashisht. Edited excerpts:


The coronavirus outbreak is continuing to spook sentiment. Despite steps taken by China, the growth forecast for India and the rest of the world have been cut. How do you see the development playing for the markets?


The Coronavirus outbreak would impact the growth not only in China but many other large economies which have trade linkages with it. This is particularly in light of the fact that China’s linkages to global GDP has

…

By:
On:


At 08:51 AM, Nifty futures on the Singapore Exchange (SGX) were trading 63 points or 0.53 per cent lower at 11,755, indicating a gap-down start for the Indian market on Wednesday.


Here’s a look at the stocks that may trade actively in today’s trading session-



Bandhan Bank: The Reserve Bank of India (RBI) has lifted the regulatory restriction on branch opening, subject to the condition that the Bank ensures that atleast 25 per cent of the total number of ‘Banking Outlets’ opened during a financial year are opened in unbanked rural centres.


Sanofi India: The company’s board has declared final dividend of Rs 106 and a special didvidend of Rs 349.


Wockhardt, Dr Reddy’s: Dr Reddy’s Laboratories (DRL) has entered into a definitive agreement with Wockhardt to acquire select divisions of its branded generics business in

…

By:
On:


The government’s target of achieving a $5 trillion economy by 2024-25 is a statement of intent, which sounds idealistic, a Niti Aayog official has said, asserting that “tough times” don’t last as she dispelled concerns over economic slowdown.


Addressing a session organised by the Merchant Chamber of Commerce and Industry (MCCI) here on Monday, Chairperson of the National Committee on Financial Inclusion and Literacy – Niti Aayog Bindu Dalmia said the target has been so set to raise the bar of India’s economic performance.



“For now, the ambitious $5 trillion economy target is a statement of intent, which sounds too idealistic,” she said, adding that the country is well on the path to achieving it.


Dispelling concerns over the slowdown, Dalmia said that tough times don’t last but tough nations do.


“There is no reason for irrational

…

By:
On:


MEDICAL DEVICES


The Central Drugs Standard Control Organization and the US Food and Drug Administration are the parties to the MoU. Sources claimed the two nations would focus on information exchange to help in capacity building.


The talks were expected to centre around medical devices, mostly the pricing regulation that India has on devices like cardiac stents. The US medical devices lobby is unhappy with the price regulations and proposals of trade margin rationalisation of devices and has indicated that such regulations hamper the introduction of innovative devices here.


Melania Trump during her visit to a government school | PTI



India has indicated all medical devices would be treated as drugs from April 1 and would be regulated under the Drugs and Cosmetics Act of 1940. The Medical Devices Rules, 2020, which will come into effect from April 1,

…